Statins provide no benefits, or adverse effects, in patients with lung cancer, according to a phase 3 trial.
Statins could be an effective agent for the treatment of patients with metastatic small cell lung cancer.
New guidelines released by the American College of Cardiology (ACC) and the American Heart Association (AHA) would have 13 million more Americans taking the cholesterol drugs, experts say.
Statin use may slow prostate cancer progression in patients receiving androgen deprivation therapy, but more trials are needed to confirm benefits, researchers say.
The use of statins for a year before a diagnosis of lung cancer is associated with a lower risk of cancer-specific mortality, but more research is needed.
Risk reduction appears sex specific, with significant reduction seen for men, but not women.
Findings among men taking a statin alongside androgen deprivation therapy showed additional months of progression-free survival.
Low density lipoprotein (LDL), or "bad cholesterol," stays the same or increases after taking statin medications.
Clinical trials on the use of statins as an anticancer drug have yielded mixed results.
Use of statins is associated with a reduced risk of progression of localized renal cell carcinoma, according to research.
- Osteoporosis Medication Improves Bone Health in ADT-Treated Prostate Cancer
- Inotuzumab Ozogamicin Granted FDA Approval for Acute Lymphoblastic Leukemia
- Coping With Lymphedema: A Patient Guide (Fact Sheet)
- Cabazitaxel in Prostate Cancer: Reduced Dose Noninferior to Standard Dose
- Risk of Some Cancers Higher in Women With a History of Periodontal Disease
- To Better Serve Patients With Cancer, Navigators Need Better Systems
- Physical Activity Improves Cognitive Function for Breast Cancer Survivors
- Risk of Lung Cancer Increases With Diets Higher in Saturated Fats
- Mechanisms Identified for Curcumin Resensitization of Cancer Cells
- Value of Type and Crossmatch Prior to Daratumumab Administration
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|